306296-73-1Relevant articles and documents
COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
-
, (2012/02/06)
Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are
PIPERAZINE DERIVATIVES USEFUL AS CCR5 ANTAGONISTS
-
Page/Page column 29, (2010/02/12)
The use is described of CCR5 antagonists of formula (I) or a pharmaceutically acceptable salt thereof, wherein: R is optionally substituted phenyl, pyridyl, thiophenyl or naphthyl; R 1 is hydrogen or alkyl; R 2 is substituted phenyl, substituted heteroary